RECOMBINATE 500 IU

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Saadav alates:

TEVA MEDICAL MARKETING LTD.

ATC kood:

B02BD05

Ravimvorm:

POWDER FOR SOLUTION FOR INJECTION

Manustamisviis:

I.V

Valmistatud:

BAXTER S.A., BELGIUM

Terapeutiline rühm:

COAGULATION FACTOR VII

Näidustused:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Loa andmise kuupäev:

2010-07-01